Obtainment and characterization of non-glycosylated recombinant monoclonal antibod...
Development of the biosimilar Fab version of the monoclonal Nivolumab (anti-PD1) a...
Production of STC-1 protein and monoclonal antibodies for therapeutic or clinical ...
Generation of cell lines with high productivity and stability for the production o...
Characterization and humanization of anti-scorpion venom and anti-TIM-3 nanobodies
Platforms developing for obtaining and characterizing non-glycosylated recombinant...